Pfizer Q3 : Profit rises 34%

by khalid on 20/10/2009 · 0 comments


The world’s biggest drugmaker, Pfizer Inc. reported the market that its profit for the Q3 of the current fiscal is $ 2.88 billion which is an increase of 34% over the corresponding Q3 of the last fiscal and it was $ 2.28 billion.

Analysts expected 48 cents per share earning, and the company beat the analysts and earned 51 cents per share. At the same time sales of the company declined 3% to $ 11.6 billion while analysts estimates it at $ 11.41 billion.

This Q3 profit of Pfizer Inc is due to aggressive cost-cutting which helped offset unfavorable foreign currency exchange rates and declining sales of drugs, including those facing competition from cheaper generics.

Pfizer acquired $ 67.3 billion Wyeth, and this deal will help the company soften the 2011 blow from the loss of U.S. patent protection on the cholesterol drug Lipitor.

Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: